journal article·2021-06

Crystal structure of eltrombopag olamine Form I, (C 2 H 8 NO) 2 (C 25 H 20 N 4 O 4 )

James A. Kaduk, Amy M. Gindhart, Thomas N. Blanton

Powder Diffraction· Volume 36· Issue 2
Publisher page

Abstract

The crystal structure of eltrombopag olamine Form I has been solved and refined using synchrotron X-ray powder diffraction data and optimized using density functional techniques. Eltrombopag olamine crystallizes in the space group P 2 1 / n (#14) with a = 17.65884(13), b = 7.55980(2), c = 22.02908(16) Å, β = 105.8749(4)°, V = 2828.665(11) Å 3 , and Z = 4. The crystal structure is dominated by columns of hydrogen-bonded cations and anions along the short b -axis. van der Waals interactions bind the columns together. Two H atoms of each ammonium group in the ethanolammonium cations participate in strong hydrogen bonds, and the third H forms weaker bifurcated H-bonds. The powder pattern has been submitted to ICDD® for inclusion in the Powder Diffraction File™ (PDF®).
Source: crossref · Quality: baseline

Research context

OpenAlex topics: X-ray Diffraction in Crystallography · Crystallography and molecular interactions · Polymer Synthesis and Characterization

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (28)

Show source-provided references
1. 10.1186/1758-2946-3-3310.1186/1758-2946-3-33 ↗
2. 10.1107/S160057671901409210.1107/S1600576719014092 ↗
3. 10.1007/BF0054909610.1007/BF00549096 ↗
4. Moore, S. (2006). “3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidine]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine),” US Patent Application 2006/0178518 A1.
5. 10.1017/S088571561400051710.1017/S0885715614000517 ↗
6. 10.1063/1.296926010.1063/1.2969260 ↗
7. Wavefunction, Inc. (2020). Spartan'18 version 1.4.0 (Wavefunction, Inc., Irvine, CA, USA).
8. 10.1107/S205252061800233010.1107/S2052520618002330 ↗
9. Turner · 2017
10. 10.1107/S002188980201523610.1107/S0021889802015236 ↗
11. 10.1063/1.46788210.1063/1.467882 ↗
12. 10.1107/S090904950801843810.1107/S0909049508018438 ↗
13. 10.1093/nar/gkaa97110.1093/nar/gkaa971 ↗
14. 2020
15. 10.1002/qua.2465810.1002/qua.24658 ↗
16. Bravais · 1866
17. Leksic, E. , Ceric, H. , Mundorfer, T. , Antonac, I. Z. , and Samardzic, Z. R. (2011). “Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereof,” US Patent Application 2011/0196008A1.
18. MDI (2020). JADE Pro version 7.8 (Computer Software) (Materials Data, Livermore, CA, USA).
19. 10.1107/S002188981301311310.1107/S0021889813013113 ↗
20. 2013
21. 10.1017/S088571561800082910.1017/S0885715618000829 ↗
22. 10.1107/S205252061600395410.1107/S2052520616003954 ↗
23. A new law of crystal morphology extending the law of Bravais
24. Etudes sur la loi de Bravais
25. 10.1107/S205252061402290210.1107/S2052520614022902 ↗
26. 10.1107/S002188981300353110.1107/S0021889813003531 ↗
27. 10.1021/ci049780b10.1021/ci049780b ↗
28. 10.1107/S002188981101462210.1107/S0021889811014622 ↗